Parasitic infection and treatment linked to cancer-related gene activity in the cervix
New research has revealed that Schistosoma haematobium (S. haematobium), a parasitic infection affecting millions globally, can trigger cancer-related gene activity in the cervical lining, with changes becoming even more pronounced after treatment.
2025-04-12
(Press-News.org) Parasitic infection and treatment linked to cancer-related gene activity in the cervix
New research has revealed that Schistosoma haematobium (S. haematobium), a parasitic infection affecting millions globally, can trigger cancer-related gene activity in the cervical lining, with changes becoming even more pronounced after treatment.1 Presented today at ESCMID Global 2025, this pivotal study sheds new light on how this often-overlooked parasitic disease may contribute to cervical cancer risk at the molecular level.
Schistosomiasis is a widespread parasitic disease, particularly prevalent in regions with poor access to clean water and sanitation.2 S. haematobium, one of the main species responsible for human schistosomiasis, infects over 110 million people worldwide by depositing eggs that infiltrate the urinary and reproductive tracts.3 While this parasite is recognised as a cause of bladder cancer, its potential role in cervical cancer has remained poorly understood.
In this study, researchers analysed cervical tissue samples from 39 Tanzanian women with (n=20) and without (n=19) S. haematobium infection. Infected women received praziquantel treatment, and samples were collected at baseline and 4-12 months post-treatment. Through RNA sequencing and gene expression analysis, cancer-related pathways linked to infection were identified. Nine genes were expressed differently between infected and uninfected women, 23 genes changed in women who cleared the infection after treatment, and 29 genes differed between women post-treatment and those never infected.
Among the nine most significantly altered genes between infected and uninfected women, four were linked to cancer:
BLK proto-oncogene: A tyrosine kinase that drives cell proliferation and can contribute to tumour formation when dysregulated
Long Intergenic Non-Protein Coding RNA 2084: A prognostic marker in head, neck, and colon cancers, influencing gene regulation tied to tumour progression
Trichohyalin: Involved in keratin complex formation and upregulated in certain cancers
TCL1 family AKT coactivator A: Promotes cell survival and proliferation, and is linked to T- and B-cell lymphomas
Post-treatment, certain cancer-related biological pathways became more active, particularly those involved in inflammation, tissue remodelling, and the breakdown of protective barriers in the cervix. These changes were linked to increased blood vessel formation, activation of tumour-related processes, and reduced programmed cell death (apoptosis)—a key mechanism for eliminating abnormal cells.
“The findings suggest that infection may trigger molecular changes that make women more vulnerable to cancer-related processes in the cervix, especially after treatment,” explains Dr. Anna Maria Mertelsmann, lead study author. “One particularly concerning observation was the downregulation of genes responsible for maintaining cervical tissue integrity, including claudins and tight junction proteins. This loss of protective function could facilitate HPV infection and persistence, a major risk factor for cervical cancer.”
“Our research shows that women who received praziquantel treatment exhibited more genetic changes linked to cancer than those with an active infection,” Dr. Mertelsmann added. “This raises critical questions about the long-term effects of treatment and highlights the need for careful post-treatment monitoring.”
This study serves as an important first step in understanding the role of S. haematobium in cervical cancer, and a larger study following 180 women over 12 months is currently underway to confirm these findings. Future research will also explore whether women who have had schistosomiasis are at greater risk of cervical cancer due to long-term HPV infections.
Dr. Mertelsmann and her team stress the need for greater awareness of Female Genital Schistosomiasis (FGS), as many women with S. haematobium are also affected by this difficult-to-diagnose condition. “Women diagnosed with S. haematobium should be closely monitored for early signs of cervical tissue abnormalities,” she emphasised. She also suggested that additional treatments—such as anti-inflammatory or immune-modulating therapies—could help counteract the harmful effects seen after treatment. Moreover, widespread HPV vaccination could play a crucial role in reducing cervical cancer risk for women affected by schistosomiasis.
ENDS
Notes to editors:
A reference to ESCMID Global must be included in all coverage and/or articles associated with this study.
For more information or to arrange an expert interview, please contact the ESCMID Press Office at: communication@escmid.org
About the study author:
Dr. Anna Maria Mertelsmann is a researcher at University Hospital Zurich and Weill Cornell Medicine, specialising in infectious diseases and molecular oncology. Her work focuses on understanding parasitic infections and their role in cancer development.
About the European Society of Clinical Microbiology and Infectious Diseases:
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is the leading society for clinical microbiology and infectious diseases in Europe. ESCMID is proud to unite over 12,000 members as well as 45,000 affiliated members through 77 national and international affiliated societies. ESCMID’s mission is to champion medical progress in infection for a healthier tomorrow and plays an important role in emerging infectious diseases and antimicrobial resistance education and research.
Website: www.escmid.org/
References:
Mertelsmann, A. M., Maganga, J. K., Lee, M. H., et al. (2025). Schistosoma haematobium infection is associated with oncogenic gene expression in cervical mucosa, with enhanced effects following treatment. Oral Presentation. ESCMID Global 2025.
World Health Organization. (2023). Schistosomiasis. Retrieved from https://www.who.int/news-room/fact-sheets/detail/schistosomiasis
Mertelsmann, A. M., Bowers, S. F., Wright, D., et al. (2024). Effects of Schistosoma haematobium infection and treatment on the systemic and mucosal immune phenotype, gene expression and microbiome: A systematic review. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012456
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-04-12
A landmark study presented today at ESCMID Global 2025 has revealed that over 3 million children worldwide lost their lives in 2022 due to antimicrobial resistance (AMR)-related infections.1
The study underscores the urgent need for both regional and global strategies to control paediatric AMR, particularly in high-burden areas such as South-East Asia and Africa. AMR poses a critical threat to children, who are highly vulnerable to infections.2 Access to new antibiotic formulations is often much more limited for children because of product development delays.
The study data found ...
2025-04-12
New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that the proportion of adolescents living with overweight or obesity in England has increased by 50% from 2008-2010 (22%) to 2021-2023 (33%). The research, presented in two studies, is by Dr Dinesh Giri, Consultant Paediatric Endocrinologist, Bristol Royal Hospital for Children and Honorary Senior Lecturer, University of Bristol, Bristol, UK, and Dr Senthil Senniappan, Consultant Paediatric Endocrinologist, Alder Hey Children’s Hospital, Liverpool, UK, and colleagues.
Previous ...
2025-04-12
The First International Conference on Cyborg and Bionic Systems (ICCBS 2025) will be held in Singapore, Republic of Singapore, from July 24 to July 26, 2025. This conference aims at providing a free, open, and diverse platform for experts, scholars, students and industry professionals from the fields of robotics, biomedical engineering, neural engineering, and related domains. The sponsor of the conference is Beijing Institute of Technology, and the organizer of the conference is the Journal Cyborg and Bionic Systems.
We look forward to welcoming experts, scholars and industry leaders from around ...
2025-04-11
Breakthrough study identifies promising biomarker for early sepsis detection in neonates, children, and pregnant women
A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including neonates, children and pregnant women. This study is the first to evaluate IL-6’s diagnostic performance in a real-world cohort across all three populations.1
Sepsis, a life-threatening condition resulting from the immune system’s overreaction to infection, remains a leading global cause of mortality, accounting ...
2025-04-11
New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that around two thirds of participants of the SURMOUNT-1 trial had only regained 5% or less of their so-called nadir (or lowest weight) three years after beginning treatment with tirzepatide. The study is by Professor Louis Aronne, Comprehensive Weight Control Center, Division of Endocrinology, Diabetes, and Metabolism, Weill Cornell Medicine, New York, NY, USA, and co-authors from Eli Lilly and Company, Indianapolis, IN, USA, which funded the study.
Obesity management is a long-term journey during which fluctuations ...
2025-04-11
Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least 3 years in adults with overweight or obesity who do not have diabetes, according to new research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May). The findings also indicate that females and those without obesity-related complications may be more responsive to tirzepatide treatment.
The study, led by Dr Luca Busetto from the University of Padova in Italy and colleagues from Eli Lilly and Company that manufacture tirzepatide, is a continuation of the SURMOUNT-1 phase 3 trial of tirzepatide, a medication approved in ...
2025-04-11
Common respiratory condition nearly triples the risk of death in adults, new study finds
A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death within one year compared to the general population.1
The findings underscore the significant, yet often under-recognised, long-term health and economic burden of RSV-ARI in adults, particularly among those with underlying conditions such as chronic obstructive pulmonary disease (COPD) and asthma.
RSV-ARI refers ...
2025-04-11
New research recently published in Archives of Sexual Behavior suggests children’s gender biases can be reflected in their facial emotional expressions.
Psychology professor Doug VanderLaan and his colleagues at the University of Toronto Mississauga, studied 296 children (148 boys and 148 girls) in Canada between the ages of four and nine years old while Wang Ivy Wong, Karen Kwan and their colleagues at the Chinese University of Hong Kong, and The Hong Kong Polytechnic University studied 309 children (155 boys and 154 girls) in Hong Kong. All children watched four short stories that included five illustrations with pre-recorded audio narratives. ...
2025-04-11
Woods Hole, Mass. (April 11, 2025) - Being a geophysicist can sometimes feel like being a detective —uncovering clues, and then building a case based on the evidence.
In a new article published in Science Advances, a collaborative team led by the Woods Hole Oceanographic Institution (WHOI), presents a never-before-seen image of an oceanic transform fault from electromagnetic (EM) data collected at the Gofar fault in the eastern Pacific Ocean. The National Science Foundation funded work reveals ...
2025-04-11
Reston, VA (April 11, 2025)—New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
Summaries of the newly published research articles are provided below.
Tracing Prostate Cancer Beyond the Usual Path
Researchers uncovered ...
LAST 30 PRESS RELEASES:
[Press-News.org] Parasitic infection and treatment linked to cancer-related gene activity in the cervix
New research has revealed that Schistosoma haematobium (S. haematobium), a parasitic infection affecting millions globally, can trigger cancer-related gene activity in the cervical lining, with changes becoming even more pronounced after treatment.
